The UK is the first country in Europe to approve Eli Lilly’s new oral weight loss management and type 2 diabetes drug, orforglipron.
Marketed under the brand name Foundayo, the tablet was authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) on...